Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $66.7 million.

  • Evolus' Total Current Liabilities rose 9.69% to $66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.7 million, marking a year-over-year increase of 9.69%. This contributed to the annual value of $63.0 million for FY2024, which is 30.38% up from last year.
  • According to the latest figures from Q3 2025, Evolus' Total Current Liabilities is $66.7 million, which was up 4.64% from $63.8 million recorded in Q2 2025.
  • In the past 5 years, Evolus' Total Current Liabilities ranged from a high of $87.6 million in Q1 2021 and a low of $40.7 million during Q1 2023.
  • Its 3-year average for Total Current Liabilities is $53.7 million, with a median of $54.1 million in 2024.
  • Over the last 5 years, Evolus' Total Current Liabilities had its largest YoY gain of 461.04% in 2021, and its largest YoY loss of 68.01% in 2021.
  • MRQ analysis of 5 years shows Evolus' Total Current Liabilities stood at $57.7 million in 2021, then fell by 19.34% to $46.5 million in 2022, then rose by 3.83% to $48.3 million in 2023, then soared by 30.38% to $63.0 million in 2024, then grew by 5.96% to $66.7 million in 2025.
  • Its Total Current Liabilities was $66.7 million in Q3 2025, compared to $63.8 million in Q2 2025 and $56.2 million in Q1 2025.